{"protocolSection": {"identificationModule": {"nctId": "NCT01721291", "orgStudyIdInfo": {"id": "NIHRCDF"}, "secondaryIdInfos": [{"id": "NIHR-CDF-2011-04-053", "type": "OTHER_GRANT", "domain": "UK - NATIONAL INSTITUTE FOR HEALTH RESEARCH"}, {"id": "2011-005544-10", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Imperial College London", "class": "OTHER"}, "briefTitle": "Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)", "officialTitle": "Improving Inhaler Treatment and Small Airways Assessment in Chronic Obstructive Pulmonary Disease (COPD)"}, "statusModule": {"statusVerifiedDate": "2022-05", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2012-10-01", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2017-11-27", "type": "ACTUAL"}, "completionDateStruct": {"date": "2017-11-27", "type": "ACTUAL"}, "studyFirstSubmitDate": "2012-10-16", "studyFirstSubmitQcDate": "2012-11-01", "studyFirstPostDateStruct": {"date": "2012-11-04", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-09-27", "resultsFirstSubmitQcDate": "2022-05-26", "resultsFirstPostDateStruct": {"date": "2023-03-06", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-05-26", "lastUpdatePostDateStruct": {"date": "2023-03-06", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Imperial College London", "class": "OTHER"}, "collaborators": [{"name": "National Institute for Health Research, United Kingdom", "class": "OTHER_GOV"}]}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "Patients with chronic obstructive pulmonary disease (COPD) experience breathing difficulties because the airways deep in their lungs become narrowed. COPD patients use inhaler drugs to provide relief from breathlessness. However, current inhalers are inefficient as they deliver a 'coarse-mist' of drug-droplets that do not reach the deep airways.\n\nIn our study, we will use an inhaler of 'fine-mist' drug-droplets, tagged with a radioactive tracer to track them. We will take images of the lungs to see if the fine-mist droplets reach the deep airways, and assess if this improves the breathing capacity in our patients. Our research may allow the development of new, more efficient inhalers to improve treatment for patients with COPD.", "detailedDescription": "PURPOSE:\n\nThe purpose of the research (or \"knowledge gap\" this research is designed to fill) is to understand the fate of inhaled drug within the lungs of COPD patients. Current inhalers in use were developed to treat asthma, which is predominantly a disease of the large airways, and these inhalers may not be optimal in treating COPD patients (which is predominantly a disease of the small airways). Poor delivery of inhaled bronchodilators to the peripheral deep airways may be a major factor limiting the clinical benefit provided by existing devices. The key to successful treatment could be to accurately target inhaled drug to the diseased lung sites, which is the hypothesis that this protocol will test.\n\nDESIGN \\& FUNDING:\n\nDr Omar Usmani has developed the research protocol and the study has been funded by the UK Government Department of Health through the NIHR (National Institute for Health Research), which funds leading edge research in the NHS focussed on the needs of patients and the public and aims to improve the health and wealth of the nation through research. The study has been peer reviewed by International Experts in this field of research.\n\nPROTOCOL:\n\nThis protocol has two studies: Lung DEPOSITION study (in COPD patients and Healthy subjects) and Lung PHYSIOLOGY study (in COPD patients and Asthmatics).\n\nEach study (Lung DEPOSITION and Lung PHYSIOLOGY) will be a randomised, double-blind, crossover, (7 treatments,controlled against pMDI salbutamol), study. Treatments will be given as one off dose administration.\n\nThere will be an interval of at least 5 days between each study visit. The Lung DEPOSITION study will involve radiolabelled drug treatments.\n\nAll the treatments in the LUNG PHYSIOLOGY study will be non-radiolabelled. Salbutamol will be the drug aerosol administered to each subject at each visit. Subjects and investigators will be blinded to the 'fine-mist' aerosol particle sizes given (at 6 treatments). The control arm will be salbutamol drug aerosol delivered as a 'coarse mist' standard metered dose inhaler (7th treatment visit).\n\nRECRUITMENT/SAMPLE SIZE; The study will recruit\u037e Lung DEPOSITION study: 12 mild-moderate COPD patients, 12 healthy subjects Lung PHYSIOLOGY study: 26 mild-moderate COPD patients, 13 mild-moderate asthmatic patients\n\nINCLUSION / EXCLUSION:\n\nAt the screening vist, no one will be unfairly excluded from the research, particularly as COPD is a disease of older age and those over 65 should not be discriminated against. This research will therefore reflect the 'real world' of COPD."}, "conditionsModule": {"conditions": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "HEALTHY SUBJECTS"], "keywords": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "SALBUTAMOL", "ALBUTEROL", "VENTOLIN", "LUNG PHYSIOLOGY", "LUNG DEPOSITION", "INHALERS", "DRUG THERAPY"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "TRIPLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 65, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "COPD 1", "type": "EXPERIMENTAL", "description": "COPD patients", "interventionNames": ["Drug: SALBUTAMOL"]}, {"label": "Healthy", "type": "EXPERIMENTAL", "description": "Healthy participants", "interventionNames": ["Drug: SALBUTAMOL"]}, {"label": "COPD 2", "type": "EXPERIMENTAL", "description": "Second group of COPD patients", "interventionNames": ["Drug: SALBUTAMOL"]}, {"label": "Asthmatics", "type": "ACTIVE_COMPARATOR", "description": "Asthmatics patients", "interventionNames": ["Drug: SALBUTAMOL"]}], "interventions": [{"type": "DRUG", "name": "SALBUTAMOL", "description": "In the LUNG DEPOSITION STUDY; SALBUTAMOL INHALED VIA RESEARCH NEBULISER at 3 PARTICLES SIZES OF 1.5 MICRONS, 3 MICRONS AND 6 MICRONS WILL BE GIVEN AT SLOW INHLATION AND AGAIN AT FAST INHALTION;DOSAGE- 30 MICROGRAMS, ONE SINGLE INHALATION ONLY. IN ADDITION, SALBUTAMOL AT 200 MICROGRAMS INHALED VIA A STANDARD METERED DOSE INHALER WILL ALSO BE GIVEN AS A SINGLE INHALATION.\n\nIn the LUNG PHYSIOLOGY STUDY; SALBUTAMOL INHALED VIA RESEARCH NEBULISER at 3 PARTICLES SIZES OF 1.5 MICRONS, 3 MICRONS AND 6 MICRONS WILL BE GIVEN AT TWO DOSAGES OF 30 MICROGRAMS AND AGAIN AT 15 MICROGRAMS, ONE SINGLE INHALATION ONLY. IN ADDITION, SALBUTAMOL AT 200 MICROGRAMS INHALED VIA A STANDARD METERED DOSE INHALER WILL ALSO BE GIVEN AS A SINGLE INHALATION. ALL INHALATIONS WIL BE AT SLOW INHALTION IN THIS PART OF THE STUDY.", "armGroupLabels": ["Asthmatics", "COPD 1", "COPD 2", "Healthy"], "otherNames": ["ALBUTEROL; VENTOLIN; SALMOL"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "ANALYSIS OF LUNG DEPOSITION - Penetration Index", "description": "Images of the lungs will be taken for radiolabelled salbutamol treatment. The images will be processed using computer software and the lungs divided into central airways (C - region) and peripheral airways (P -region). We will analyse the amount of radiolabelled salbutamol in each region and calculate how deep into the lungs the inhaled salbutamol has reached by using the ratio C/P which is known as the Penetration Index.", "timeFrame": "5 MINUTES AFTER INHALATION OF SALBUTAMOL"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n- COPD patients, either male or female, over the age of 40 with a clinical diagnosis of COPD with airflow obstruction(FEV1/FVC\\<0.7) and post-bronchodilator FEV1\\>50% predicted, gas trapping (on lung volume testing), and decreased carbon monoxide transfer factor.\n\nHealthy subjects will be nonsmokers(or exsmokers stopped 5 years ago), will have no respiratory disease, normal spirometry and be age-matched to the COPD patients.\n\nAsthmatic subjects, either male or female, over the age of 18 with a clinical diagnosis of Asthma with airflow obstruction (FEV1/FVC\\<0.7).\n\nAll patients should be capable of giving informed consent.\n\nExclusion Criteria:\n\n1. Oral corticosteroids taken within last month.\n2. Current involvement (or involvement in the last 4 weeks)in clinical trials assessing investigational medicinal products.\n3. Previous adverse reaction to short or long acting \u03b22 agonist.\n4. Any subject with a contraindication to taking inhaled beta2-adrenoceptor agonists (especially salbutamol) as listed in the British National Formulary will not be entered into this study.\n5. Those who have experienced an acute respiratory exacerbation requiring emergency room treatment and/ or hospitalisation within four weeks of visit 1 (screening visit).\n6. Pregnant or breastfeeding women.\n7. Subjects unable to give Informed Consent.", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Omar S USMANI, MD, PhD", "affiliation": "Imperial College London", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Royal Brompton Hospital & Imperial College London", "city": "London", "zip": "SW3 6LY", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}]}, "referencesModule": {"references": [{"pmid": "16192448", "type": "BACKGROUND", "citation": "Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1497-504. doi: 10.1164/rccm.200410-1414OC. Epub 2005 Sep 28."}], "seeAlsoLinks": [{"label": "INFORMATION ON THE UK-NATIONAL INSTITUTE FOR HEALTH RESEARCH", "url": "http://www.nihr.ac.uk/about/Pages/default.aspx"}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "This protocol has two studies: Lung DEPOSITION study (in COPD patients and Healthy subjects) and Lung PHYSIOLOGY study (in COPD patients and Asthmatics).", "groups": [{"id": "FG000", "title": "COPD- Lung DEPOSITION Study", "description": "Lung DEPOSITION study COPD patients All participant received SALBUTAMOL INHALED VIA RESEARCH NEBULISER at 3 PARTICLES SIZES OF 1.5 MICRONS, 3 MICRONS AND 6 MICRONS GIVEN AT SLOW INHLATION AND AGAIN AT FAST INHALTION;DOSAGE- 30 MICROGRAMS, ONE SINGLE INHALATION ONLY. IN ADDITION, SALBUTAMOL AT 200 MICROGRAMS INHALED VIA A STANDARD METERED DOSE INHALER GIVEN AS A SINGLE INHALATION."}, {"id": "FG001", "title": "Healthy - Lung DEPOSITION Study", "description": "Lung DEPOSITION study\n\nHealthy participants received:\n\nSALBUTAMOL INHALED VIA RESEARCH NEBULISER at 3 PARTICLES SIZES OF 1.5 MICRONS, 3 MICRONS AND 6 MICRONS GIVEN AT SLOW INHLATION AND AGAIN AT FAST INHALTION;DOSAGE- 30 MICROGRAMS, ONE SINGLE INHALATION ONLY. IN ADDITION, SALBUTAMOL AT 200 MICROGRAMS INHALED VIA A STANDARD METERED DOSE INHALER GIVEN AS A SINGLE INHALATION."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "did not like the treatment", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "COPD", "description": "COPD patients"}, {"id": "BG001", "title": "Healthy", "description": "Healthy participants"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "26"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "26"}]}], "categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "10"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "16"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "26"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "66.08", "lowerLimit": "56", "upperLimit": "77"}, {"groupId": "BG001", "value": "64.08", "lowerLimit": "50", "upperLimit": "76"}, {"groupId": "BG002", "value": "65.08", "lowerLimit": "50", "upperLimit": "77"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "26"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "13"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "13"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United Kingdom", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "26"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "65"}]}]}]}, {"title": "Force experation in 1s (FEV1)", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "litre", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "26"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1.63", "lowerLimit": "0.97", "upperLimit": "2.24"}, {"groupId": "BG001", "value": "2.55", "lowerLimit": "1.55", "upperLimit": "3.76"}, {"groupId": "BG002", "value": "2.12", "lowerLimit": "0.71", "upperLimit": "3.9"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "ANALYSIS OF LUNG DEPOSITION - Penetration Index", "description": "Images of the lungs will be taken for radiolabelled salbutamol treatment. The images will be processed using computer software and the lungs divided into central airways (C - region) and peripheral airways (P -region). We will analyse the amount of radiolabelled salbutamol in each region and calculate how deep into the lungs the inhaled salbutamol has reached by using the ratio C/P which is known as the Penetration Index.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ratio", "timeFrame": "5 MINUTES AFTER INHALATION OF SALBUTAMOL", "groups": [{"id": "OG000", "title": "Healthy_1.5um Slow", "description": "Healthy participants Salbutamol 1.5um slow"}, {"id": "OG001", "title": "Healthy_1.5um Fast", "description": "Healthy participants Salbutamol 1.5um fast"}, {"id": "OG002", "title": "COPD 1_1.5um Slow", "description": "COPD patients Salbutamol 1.5um slow"}, {"id": "OG003", "title": "COPD1_1.5um Fast", "description": "Second group of COPD patients Salbutamol 1.5um fast"}, {"id": "OG004", "title": "Healthy_3um Slow", "description": "Healthy participants Salbutamol 3um slow"}, {"id": "OG005", "title": "Healthy_3um Fast", "description": "Healthy participants Salbutamol 3um fast"}, {"id": "OG006", "title": "COPD_3um Slow", "description": "COPD patients Salbutamol 3um slow"}, {"id": "OG007", "title": "COPD_3um Fast", "description": "COPD patients Salbutamol 3um fast"}, {"id": "OG008", "title": "Healthy_6um Slow", "description": "Healthy participants Salbutamol 6um slow"}, {"id": "OG009", "title": "Healthy_6um Fast", "description": "Healthy participants Salbutamol 6um fast"}, {"id": "OG010", "title": "COPD_6um Slow", "description": "COPD patients Salbutamol 6um slow"}, {"id": "OG011", "title": "COPD_6um Fast", "description": "COPD patients Salbutamol 6um fast"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "12"}, {"groupId": "OG004", "value": "12"}, {"groupId": "OG005", "value": "12"}, {"groupId": "OG006", "value": "12"}, {"groupId": "OG007", "value": "12"}, {"groupId": "OG008", "value": "12"}, {"groupId": "OG009", "value": "12"}, {"groupId": "OG010", "value": "12"}, {"groupId": "OG011", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "0.08"}, {"groupId": "OG001", "value": "0.72", "spread": "0.12"}, {"groupId": "OG002", "value": "0.69", "spread": "0.13"}, {"groupId": "OG003", "value": "0.58", "spread": "0.14"}, {"groupId": "OG004", "value": "0.75", "spread": "0.11"}, {"groupId": "OG005", "value": "0.63", "spread": "0.15"}, {"groupId": "OG006", "value": "0.65", "spread": "0.18"}, {"groupId": "OG007", "value": "0.48", "spread": "0.16"}, {"groupId": "OG008", "value": "0.51", "spread": "0.1"}, {"groupId": "OG009", "value": "0.46", "spread": "0.04"}, {"groupId": "OG010", "value": "0.37", "spread": "0.12"}, {"groupId": "OG011", "value": "0.32", "spread": "0.08"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "6 month", "eventGroups": [{"id": "EG000", "title": "Healthy_1.5um Slow", "description": "Healthy participants received Salbutamol 1.5um slow - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 12, "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}, {"id": "EG001", "title": "Healthy_1.5um Fast", "description": "Healthy participants received Salbutamol 1.5um fast - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 12, "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}, {"id": "EG002", "title": "COPD_1.5um Slow", "description": "Participants with COPD received Salbutamol 1.5um slow - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 1, "otherNumAtRisk": 14}, {"id": "EG003", "title": "COPD_1.5um Fast", "description": "Participants with COPD received Salbutamol 1.5um fast - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 1, "otherNumAtRisk": 14}, {"id": "EG004", "title": "Healthy_3um Slow", "description": "Healthy participants received Salbutamol 3um slow - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 12, "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}, {"id": "EG005", "title": "Healthy_3um Fast", "description": "Healthy participants received Salbutamol 3um fast - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 12, "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}, {"id": "EG006", "title": "COPD_3um Slow", "description": "Participants with received COPD Salbutamol 3um slow - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 1, "otherNumAtRisk": 14}, {"id": "EG007", "title": "COPD_3um Fast", "description": "Participants with COPD Salbutamol 3um fast - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 0, "otherNumAtRisk": 14}, {"id": "EG008", "title": "Healthy_6um Slow", "description": "Healthy participants received Salbutamol 6um slow - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 12, "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 1, "otherNumAtRisk": 12}, {"id": "EG009", "title": "Healthy_6um Fast", "description": "Healthy participants received Salbutamol 6um fast - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 12, "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}, {"id": "EG010", "title": "COPD_6um Slow", "description": "Participants with COPD received Salbutamol 6um slow - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 1, "otherNumAtRisk": 14}, {"id": "EG011", "title": "COPD_6um Fast", "description": "Participants with COPD received Salbutamol 6um fast - Lung DEPOSITION study", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 0, "otherNumAtRisk": 14}], "otherEvents": [{"term": "Hypertension", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG008", "numEvents": 1, "numAffected": 1, "numAtRisk": 12}, {"groupId": "EG009", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG010", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG011", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}]}, {"term": "Diarrhoe", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG008", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG009", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG010", "numEvents": 1, "numAffected": 1, "numAtRisk": 14}, {"groupId": "EG011", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}]}, {"term": "Pulled muscle", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 14}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG008", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG009", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG010", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG011", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}]}, {"term": "Chest infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 14}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG008", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG009", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG010", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG011", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}]}, {"term": "Sore throat", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG008", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG009", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG010", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG011", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}]}, {"term": "Cataract operatoin", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG008", "numEvents": 1, "numAffected": 1, "numAtRisk": 12}, {"groupId": "EG009", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG010", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG011", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}]}, {"term": "Flu", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (10.0)", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 14}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG008", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG009", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG010", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}, {"groupId": "EG011", "numEvents": 0, "numAffected": 0, "numAtRisk": 14}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Dr Omar Usmani", "organization": "Imperial College London", "email": "o.usmani@imperial.ac.uk", "phone": "+440(0) 207351 8051"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2011-10-20", "uploadDate": "2019-09-27T08:41", "filename": "Prot_SAP_000.pdf", "size": 342871}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000029424", "term": "Pulmonary Disease, Chronic Obstructive"}], "ancestors": [{"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000002908", "term": "Chronic Disease"}, {"id": "D000020969", "term": "Disease Attributes"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "asFound": "Pulmonary Disease", "relevance": "HIGH"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "asFound": "Obstructive Pulmonary Disease", "relevance": "HIGH"}, {"id": "M23449", "name": "Pulmonary Disease, Chronic Obstructive", "asFound": "Chronic Obstructive Pulmonary Disease", "relevance": "HIGH"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M6147", "name": "Chronic Disease", "relevance": "LOW"}, {"id": "M22700", "name": "Disease Attributes", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "asFound": "Chronic", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000000420", "term": "Albuterol"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M3767", "name": "Albuterol", "asFound": "Diameter", "relevance": "HIGH"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}